Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania

被引:0
作者
Maillie, Luke [1 ]
Yussuph, Amina [2 ]
Chirangi, Bwire [3 ]
Schroeder, Kristin [2 ,4 ,5 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Bugando Med Ctr, Dept Oncol, Mwanza, Tanzania
[3] Shirati KMT Council Designated Hosp, Mara, Tanzania
[4] Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC USA
[5] Duke Univ, Duke Global Canc Program, Med Ctr, Durham, NC USA
关键词
cervical cancer; screen-and-treat; Sub-Saharan Africa; Tanzania; VISUAL INSPECTION; VACCINATION; HEALTH; INDIA; COST;
D O I
10.1002/ijgo.14429
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To examine screening outcomes for a rural screen-and-treat site as well as the referral completion rate, outreach programming, and screening costs. Methods A retrospective cross-sectional analysis of demographic information and screening outcomes for all women screened at a rural screen-and-treat site between August 2011 and December 2018 was conducted. Referral completion rate for women with suspected cervical cancer was calculated for 2018. Results A total of 10 157 screenings were conducted during the study period. Median age was 35 years and median parity was 5. In all, 545 (5.35%) women were positive on visual inspection with acetic acid (VIA+), and 461 (91.1%) of 506 eligible women received cryotherapy. In 2018, 93 women were referred for suspected cancer to the zonal referral center, but only 10 (10.8%) presented for treatment. Mean screening cost was US$ 6.62 per person. Conclusion VIA+ rate was comparable to rates at urban sites in Tanzania, and outreach was an important component of screening. In contrast to other reports, few women suspected of having cancer reached treatment after being referred. Although the low cost of screening highlights the feasibility of rural screen-and-treat sites, additional research is needed to improve completion of referrals to a higher level of care.
引用
收藏
页码:604 / 611
页数:8
相关论文
共 50 条
  • [31] Tanzanian women′s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017-2019
    Henke, Antje
    Kluge, Ulrike
    Borde, Theda
    Mchome, Bariki
    Serventi, Furaha
    Henke, Oliver
    GLOBAL HEALTH ACTION, 2021, 14 (01)
  • [32] Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics
    Ivana Di Salvo
    Dorcas Mnzava
    Giovanni Jacopo Nicoletti
    Elizabeth Senkoro
    Robert C. Ndege
    Dorothy J. Huang
    Nathalia Tobias Makunja
    George I. Kassiga
    Andreas M. Kaufmann
    Maja Weisser
    André B. Kind
    BMC Health Services Research, 23
  • [33] Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa
    Domgue, Joel Fokom
    Futuh, Beatrice
    Ngalla, Calvin
    Kakute, Peter
    Manjuh, Florence
    Manga, Simon
    Nulah, Kathleen
    Welty, Edith
    Schmeler, Kathleen
    Welty, Thomas
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 128 - 138
  • [34] From potential to practice: how accelerating access to HPV tests and screen and treat programmes can help eliminate cervical cancer
    Cherniak, William
    Tyler, Nikki
    Arora, Kriti
    Lapidos-Salaiz, Ilana
    Sczudlo, Emma
    Lin, Amy
    Barnhart, Matthew
    Flanigan, John
    Silkensen, Shannon
    FAMILY MEDICINE AND COMMUNITY HEALTH, 2019, 7 (04)
  • [35] Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey
    Joelle I. Rosser
    Sabina Hamisi
    Betty Njoroge
    Megan J. Huchko
    Journal of Community Health, 2015, 40 : 756 - 761
  • [36] Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria
    Babayemi O. Olakunde
    Ijeoma U. Itanyi
    John O. Olawepo
    Lin Liu
    Chinenye Bembir
    Ngozi Idemili-Aronu
    Nwamaka N. Lasebikan
    Tonia C. Onyeka
    Cyril C. Dim
    Chibuike O. Chigbu
    Echezona E. Ezeanolue
    Gregory A. Aarons
    Implementation Science, 19
  • [37] Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study
    Gard, Andrew C.
    Soliman, Amr S.
    Ngoma, Twalib
    Mwaiselage, Julius
    Kahesa, Crispin
    Chamberlain, Robert M.
    Harlow, Sioban D.
    BMC PUBLIC HEALTH, 2014, 14
  • [38] Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study
    Andrew C Gard
    Amr S Soliman
    Twalib Ngoma
    Julius Mwaiselage
    Crispin Kahesa
    Robert M Chamberlain
    Siobán D Harlow
    BMC Public Health, 14
  • [39] Social Support and Cervical and Breast Cancer Screening in Argentinean Women From a Rural Population
    Gamarra, Carmen Justina
    Araujo Paz, Elisabete Pimenta
    Griep, Rosane Harter
    PUBLIC HEALTH NURSING, 2009, 26 (03) : 269 - 276
  • [40] Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey
    Okyere, Joshua
    Ayebeng, Castro
    Dosoo, Abigail Kabukie
    Dickson, Kwamena Sekyi
    BMC PUBLIC HEALTH, 2024, 24 (01)